Home / Research / Clearances / K172913 Public FDA record
K172913: cobas Factor II and Factor V Test 510(k) clearance K172913 for Roche Molecular Systems, Inc.. View source facts, labeled dates, and the original FDA record.
FDA identifier K172913
Company in FDA record Roche Molecular Systems, Inc.
FDA decision date Jan 12, 2018
First observed by MedTech Watch Nov 16, 2026
Latest observed content change Nov 17, 2026 Decision stated in the source Substantially Equivalent Source facts
Decision Substantially Equivalent
Received 2017-09-25
Specialty Hematology
Decision code SESE
Clearance type Traditional Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Keep following this market Carry a company or product code into your watchlist for ongoing matching and a weekly brief.
Roche Molecular Systems Inc
14 days free. No card required. Then $49/month when you choose to subscribe.
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗